Ex) Article Title, Author, Keywords
Ex) Article Title, Author, Keywords
Clinical Pain 2017; 16(2): 77-83
Published online December 31, 2017
Copyright © Korean Association of Pain Medicine.
Hyo Sun Lee, M.D.1, Jong Geol Do, M.D.2 and Sang Jun Kim, M.D., Ph.D.2
이효선1ㆍ도종걸2ㆍ김상준1
Objective: To identify factors related to prognosis in patients with rotator cuff calcific tendinitis and to predict the clinical outcomes of calcific tendinitis. Method: Patients who were diagnosed with calcific tendinitis of supraspinatus tendon from January 2014 to December 2015 were selected and their med-ical records were reviewed. Pearson χ2-test was conducted to investigate the relationships between prognosis and categorical variables of gender, pretreatment numerical rating scale, calcification type, and treatment modality. Univariate logistic regression analysis was performed to determine the prognosis of clinical outcomes of rotator calcific tendinitis. Results: The relationship between prognosis of the calcific tendinitis and treatment modality showed a significant difference. It showed the most favorable prognosis in the barbotage group (χ2= 6.259, p=0.044) compared with extracorporeal shockwave therapy (ESWT), nonsteroidal anti-inflammatory drug (NSAIDs) and physical therapy. Univariate logistic regression analysis showed that only calcium barbotage was correlated with prognosis (odds ratio=0.164, p=0.016). There was a significant difference in prognosis between modalities for type III calcification (χ2=6.589, p=0.037). Conclusion: Prognosis of calcific tendinitis at 1 year after treatment was related to treatment modality and was better in the barbotage group compared to other nonsurgical treatments including ESWT, NSAIDs and physical therapy. This difference between treatment modalities was especially evident in type III calcification. (Clinical Pain 2017;16:77-83)
KeywordsRotator cuff, Calcific tendinitis, Prognosis, Barbotage